Allergan acquiring Herald Pharmacal nonprescription skin care business.
This article was originally published in The Rose Sheet
Executive Summary
ALLERGAN ACQUIRING HERALD PHARMACAL SKIN CARE BUSINESS, for an undisclosed amount, Allergan announced Aug. 1. The companies have signed a definitive agreement regarding the acquisition. Herald Pharmacal markets a wide range of nonprescription glycolic acid-based skin care products. The M.D. Formulations brand is sold through dermatologists, plastic surgeons and aestheticians and the Aqua Glycolic line is marketed through pharmacies. Herald had sales of $15-20 mil. in fiscal 1995 ended July 31, according to Allergan.